Loading clinical trials...
Loading clinical trials...
A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674, and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics
Conditions
Interventions
Cilofexor
Placebo
Locations
1
United States
SeaView Research, Inc
Miami, Florida, United States
Start Date
January 20, 2016
Primary Completion Date
July 14, 2016
Completion Date
July 14, 2016
Last Updated
October 12, 2020
NCT06318169
NCT05842512
NCT06216041
NCT04104321
NCT02443116
NCT04616014
Lead Sponsor
Gilead Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions